bioMérieux, recognized as a leader in in vitro diagnostics, has introduced GENE-UP TYPER, a real-time PCR solution designed for the rapid detection of pathogens in the food industry. This new technology aims to assist food manufacturers in identifying the root causes of contamination, which is critical given that the World Health Organization estimates that 600 million people suffer from foodborne illnesses annually. Such incidents can have significant health implications and lead to costly product recalls and reputational harm for companies in the food sector.
The GENE-UP TYPER system operates within the GENE-UP platform, providing an automated method for pathogen detection. Upon detecting a pathogen during routine testing, the process involves isolating the strains, extracting DNA, and amplifying it using specific assays. The results are then analyzed through the AUGMENTED-DX web application, which utilizes machine learning algorithms to categorize strains and track their history within production facilities. This capability aids in tracing contamination sources, thereby enhancing production control.
bioMérieux has a long-standing commitment to innovation within the food processing industry, with over 30 years of experience in industrial applications. The development of GENE-UP TYPER reflects ongoing investments in scientific advancements aimed at improving food safety. The company collaborates with Mérieux NutriSciences, which holds co-exclusive rights for testing in certain regions, ensuring that the solution is accessible to food and beverage manufacturers regardless of their testing capabilities.
The first assay available through this system targets Listeria monocytogenes, marking a significant step in pathogen detection for food manufacturers globally. For further details, interested parties can visit bioMérieux’s website.